secnidazole bacterial vaginosis
Selected indexed studies
- Secnidazole for treatment of bacterial vaginosis: a systematic review. (BMC Womens Health, 2019) [PMID:31638955]
- Secnidazole (Solosec) for Bacterial Vaginosis. (Am Fam Physician, 2019) [PMID:31414782]
- Efficacy and safety of single dose of oral secnidazole 2 g in treatment of bacterial vaginosis: A systematic review and meta-analysis. (Eur J Obstet Gynecol Reprod Biol, 2019) [PMID:31129560]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Secnidazole. (2006) pubmed
- Secnidazole for treatment of bacterial vaginosis: a systematic review. (2019) pubmed
- Secnidazole (Solosec) for Bacterial Vaginosis. (2019) pubmed
- Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis. (1996) pubmed
- Efficacy and safety of single dose of oral secnidazole 2 g in treatment of bacterial vaginosis: A systematic review and meta-analysis. (2019) pubmed
- Secnidazole (Solosec) for bacterial vaginosis. (2018) pubmed
- Secnidazole Treatment of Bacterial Vaginosis: A Randomized Controlled Trial. (2017) pubmed
- Bacterial vaginosis and surgical site infections. (2020) pubmed
- Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment. (2018) pubmed
- Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin. (2017) pubmed